Stifel Reiterates NuVasive (NUVA) at Buy, Ongoing Product Launches Should Support Strong Growth Rate
Tweet Send to a Friend
Stifel analyst Mathew Blackman reiterated a Buy rating and $65.00 price target on NuVasive (NASDAQ: NUVA), following the company's most ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
